Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 08, 2023

BUY
$132.34 - $159.14 $16,013 - $19,255
121 Added 7.46%
1,743 $277,000
Q4 2022

Feb 07, 2023

SELL
$102.55 - $135.33 $15,382 - $20,299
-150 Reduced 8.47%
1,622 $219,000
Q3 2022

Nov 01, 2022

BUY
$95.28 - $116.93 $11,433 - $14,031
120 Added 7.26%
1,772 $177,000
Q2 2022

Aug 04, 2022

SELL
$103.24 - $121.81 $126,778 - $149,582
-1,228 Reduced 42.64%
1,652 $184,000
Q1 2022

May 09, 2022

BUY
$93.1 - $112.54 $49,343 - $59,646
530 Added 22.55%
2,880 $320,000
Q4 2021

Feb 07, 2022

BUY
$95.88 - $117.08 $225,318 - $275,138
2,350 New
2,350 $256,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $190B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Mitsubishi Ufj Kokusai Asset Management Co., Ltd. Portfolio

Follow Mitsubishi Ufj Kokusai Asset Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mitsubishi Ufj Kokusai Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mitsubishi Ufj Kokusai Asset Management Co., Ltd. with notifications on news.